KR20170026486A - 저혈압 치료 방법 - Google Patents

저혈압 치료 방법 Download PDF

Info

Publication number
KR20170026486A
KR20170026486A KR1020177001649A KR20177001649A KR20170026486A KR 20170026486 A KR20170026486 A KR 20170026486A KR 1020177001649 A KR1020177001649 A KR 1020177001649A KR 20177001649 A KR20177001649 A KR 20177001649A KR 20170026486 A KR20170026486 A KR 20170026486A
Authority
KR
South Korea
Prior art keywords
angiotensin
patient
composition
rate
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020177001649A
Other languages
English (en)
Korean (ko)
Inventor
조지 티드마시
Original Assignee
라 졸라 파마슈티칼 컴파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라 졸라 파마슈티칼 컴파니 filed Critical 라 졸라 파마슈티칼 컴파니
Publication of KR20170026486A publication Critical patent/KR20170026486A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR1020177001649A 2014-07-08 2015-07-08 저혈압 치료 방법 Ceased KR20170026486A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462022054P 2014-07-08 2014-07-08
US62/022,054 2014-07-08
PCT/US2015/039499 WO2016007589A1 (en) 2014-07-08 2015-07-08 Methods for treating hypotension

Publications (1)

Publication Number Publication Date
KR20170026486A true KR20170026486A (ko) 2017-03-08

Family

ID=55064810

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177001649A Ceased KR20170026486A (ko) 2014-07-08 2015-07-08 저혈압 치료 방법

Country Status (14)

Country Link
US (3) US20160074465A1 (enExample)
EP (2) EP3007722A4 (enExample)
JP (2) JP2017519799A (enExample)
KR (1) KR20170026486A (enExample)
CN (1) CN106794224A (enExample)
AU (2) AU2015287955A1 (enExample)
BR (1) BR112017000303A2 (enExample)
CA (1) CA2954016A1 (enExample)
EA (2) EA036514B1 (enExample)
IL (1) IL249936A0 (enExample)
MX (1) MX2017000306A (enExample)
SG (2) SG10201804034QA (enExample)
TW (3) TWI754225B (enExample)
WO (1) WO2016007589A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200046957A (ko) 2018-10-26 2020-05-07 양성심 유기농 케일을 주 성분으로 하는 건강기능식품 조성물

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
LT2986308T (lt) 2013-12-18 2020-03-25 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzino ii derinys hipotenzijai gydyti
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
AU2017205168A1 (en) 2016-01-07 2018-08-16 La Jolla Pharma, Llc Methods for administering angiotensin II
WO2018191678A1 (en) * 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
TW201927331A (zh) * 2017-12-15 2019-07-16 美商拉荷亞製藥公司 血管收縮素組合物及與其相關之方法
CA3093725C (en) 2018-03-23 2021-08-24 Nevakar Inc. Epinephrine compositions and containers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
ATE507243T1 (de) * 2005-09-29 2011-05-15 Fibrogen Inc Verfahren zur senkung des blutdrucks
MX2011005672A (es) * 2008-11-28 2011-06-20 Abbott Lab Composiciones de anticuerpo estables y metodos para estabilizar a las mismas.
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
LT2986308T (lt) * 2013-12-18 2020-03-25 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzino ii derinys hipotenzijai gydyti

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200046957A (ko) 2018-10-26 2020-05-07 양성심 유기농 케일을 주 성분으로 하는 건강기능식품 조성물

Also Published As

Publication number Publication date
SG11201610897VA (en) 2017-01-27
CN106794224A (zh) 2017-05-31
JP2020143139A (ja) 2020-09-10
EA202091873A2 (ru) 2020-11-30
TWI754225B (zh) 2022-02-01
WO2016007589A1 (en) 2016-01-14
IL249936A0 (en) 2017-03-30
EP3007722A1 (en) 2016-04-20
MX2017000306A (es) 2017-07-10
TW202038927A (zh) 2020-11-01
EA202091873A3 (ru) 2021-01-29
EA036514B1 (ru) 2020-11-18
TW201625231A (zh) 2016-07-16
SG10201804034QA (en) 2018-07-30
EP3381465A1 (en) 2018-10-03
TWI688385B (zh) 2020-03-21
US20160074465A1 (en) 2016-03-17
BR112017000303A2 (pt) 2017-11-07
CA2954016A1 (en) 2016-01-14
US20200237853A1 (en) 2020-07-30
AU2021201669A1 (en) 2021-04-08
EA201692534A1 (ru) 2017-06-30
US20180311306A1 (en) 2018-11-01
AU2015287955A1 (en) 2017-02-02
EP3007722A4 (en) 2016-05-25
TW202214219A (zh) 2022-04-16
JP2017519799A (ja) 2017-07-20

Similar Documents

Publication Publication Date Title
TWI688385B (zh) 治療低血壓之方法
KR20180108630A (ko) 혈관수축제의 투여 방법
US11219662B2 (en) Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II
US20140329747A1 (en) Compositions and Methods for Treating Renal Failure
US11583568B2 (en) Methods for administering angiotensin II
RS59804B1 (sr) Angiotenzin ii u kombinaciji za lečenje hipotenzije
HK1238562A1 (en) Methods for treating hypotension
WO2020252333A1 (en) Methods for administering angiotensin ii by monitoring renin levels
CA2910601C (en) Compositions and methods for treating renal failure
WO2020018785A1 (en) Methods of treating angioedema
HK1224580A1 (en) Compositions and methods for treating renal failure

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20170119

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200708

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220617

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20221024

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20220617

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I